Among the 21 patients in whom both primary site and metastases were available for EGFR methylation study, EGFR methylation status of primary tumour was in accordance with that of metastasis in 16 patients (76%): 4 patients with EGFR promoter hypermethylation and 12 patients with unmethylated tumours. Here, EGFR is linked to neoplasm.